- Home
- CDLX vs AMRN Comparison
CDLX vs AMRN Comparison
Compare CDLX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLX
- AMRN
- Stock Information
- Founded
- CDLX 2008
- AMRN 1989
- Country
- CDLX United States
- AMRN Ireland
- Employees
- CDLX N/A
- AMRN N/A
- Industry
- CDLX Computer Software: Programming Data Processing
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- CDLX Technology
- AMRN Health Care
- Exchange
- CDLX Nasdaq
- AMRN Nasdaq
- Market Cap
- CDLX 180.4M
- AMRN 189.2M
- IPO Year
- CDLX 2018
- AMRN 1993
- Fundamental
- Price
- CDLX $3.37
- AMRN $0.57
- Analyst Decision
- CDLX Hold
- AMRN Buy
- Analyst Count
- CDLX 6
- AMRN 1
- Target Price
- CDLX $5.90
- AMRN N/A
- AVG Volume (30 Days)
- CDLX 936.2K
- AMRN 1.7M
- Earning Date
- CDLX 03-13-2025
- AMRN 02-27-2025
- Dividend Yield
- CDLX N/A
- AMRN N/A
- EPS Growth
- CDLX N/A
- AMRN N/A
- EPS
- CDLX N/A
- AMRN N/A
- Revenue
- CDLX $293,468,000.00
- AMRN $241,021,000.00
- Revenue This Year
- CDLX N/A
- AMRN N/A
- Revenue Next Year
- CDLX $3.49
- AMRN N/A
- P/E Ratio
- CDLX N/A
- AMRN N/A
- Revenue Growth
- CDLX N/A
- AMRN N/A
- 52 Week Low
- CDLX $2.76
- AMRN $0.43
- 52 Week High
- CDLX $20.52
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- CDLX 43.28
- AMRN 55.80
- Support Level
- CDLX $2.76
- AMRN $0.43
- Resistance Level
- CDLX $3.92
- AMRN $0.49
- Average True Range (ATR)
- CDLX 0.25
- AMRN 0.03
- MACD
- CDLX -0.03
- AMRN 0.01
- Stochastic Oscillator
- CDLX 40.70
- AMRN 79.29
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.